A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)
Clinical trial NCT01511003 · COMPLETED
Trial details
- NCT number
- NCT01511003
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-05
- Primary completion
- 2015-05-11
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.